News

ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...
A higher baseline HIV viral load increases the odds of an immunologic response in women living with HIV, except among those ...
Earlier versions of a spending cuts package passed through Congress targeted PEPFAR. But the White House, concerned about ...
Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...
Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...
All I want is for HIV to end with me,” says a young woman renamed Dorothy Banda to safeguard her identity, rights and ...
Three decades after Rae Lewis-Thornton became the face of HIV, the virus is still a major threat to Black women. She and experts explore why.
The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...
Participants who initiated long-acting cabotegravir-rilpivirine had a high rate of adherence and virologic suppression, with ...
After the virologic failure of cabotegravir/rilpivirine and despite dual-class resistance mutations, Canadian doctors have ...
When Robert Smith met his future girlfriend in 2010, he wanted to take things slowly. For Smith, no relationship had been ...